Hospital Umum Sarawak

Kuching, Sarawak 93586

2 studies enrolling now · 10 studies all time

What they study most

Adnexal Mass, Beta-Thalassemia, Beta-thalassemia, COVID-19, Erythrocyte Transfusion, Hemophilia A, Melanoma, Myelodysplastic Syndromes (MDS), Myeloproliferative Neoplasm(MPN)-Associated Myelofibrosis, Neurogenic Detrusor Overactivity, Neuromyelitis Optica, Neuromyelitis Optica Spectrum Disorder

Studies at this site

• A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials — Recruiting now
• Open-label, Long-term Safety, Efficacy, and Pharmacokinetics Study of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age With NDO and on CIC — Recruiting now
• A Study to Evaluate Similarity of ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Resected Melanoma — Completed
• EPIC-HR: Study of Oral PF-07321332/Ritonavir Compared With Placebo in Nonhospitalized High Risk Adults With COVID-19 — Completed
• Clinical Validation of the InterVenn Ovarian CAncer Liquid Biopsy — Completed
• An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Adults Who Require Regular Red Blood Cell Transfusions Due to Beta (β) Thalassemia — Completed
• An Open Label Extension Trial of Eculizumab in Relapsing NMO Patients — Completed
• BAX 855 Continuation — Completed
• BAX 855 Pediatric Study — Completed
• A Phase II Study of M2951 in SLE — Stopped early